🚀 Elephas: Cancer's worst enemy

The biotechnology company aiming to cure cancer

September 05, 2023

Cancer is a leading cause of death worldwide, with the number of patients projected to triple by 2060. Elephas aims to change this with a real-time tumor testing platform without harming patients.

⚾ The Elevator Pitch

Only about 1 in 3 cancer patients see positive results in treatment.

Elephas is changing that. They're using cutting-edge technology like microscopy and AI to understand how tumors respond to different treatments, aiming to make cancer care much more effective. By analyzing tumor samples in real-time, Elephas is bringing us closer to a future where cancer treatments are personalized and successful for more patients.

Elephas currently has 2 FDA-sponsored clinical trials in progress - check them out below!

👇 The Drop Down

💻 Site: https://elephas.com/

📈 Founded: 2021

🧬 Tech Trend: Biotech

🦶 Traction: Raised over $60M in total in only 2 years of operations; featured on Business Wire

👥 Team: Ex-Illumina Leads and Johns Hopkins medical graduates (Founders: Dr. Jonathan D. Oliner and Maneesh K. Arora)

🔍 Why we like it

1. 💡 Cancer innovation needs a new approach

Elephas is a special company because they're doing things in a new way. Instead of just making drugs, they're developing a smart system that helps try out treatments on tiny pieces of the tumor, like a test cancer treatment external to the patient. This can give doctors quick feedback without hurting the patient. It's like trying out keys to see which one opens the door, but much safer and for treating cancer.

2. 🏃💨 Elephas moves quickly

Elephas understands that every second matters in healthcare. Diseases wait for no one, and Elephas has already dived into 2 clinical trials 1 year after their initial funding. Faster treatment development means that effective treatments can reach patients sooner and those patients can go back to living the lives they deserve.

3. 🧑‍🏫 They remain committed to the truth

A cornerstone of academic work is remaining loyal to the truth. This is why the success of an academic is not measured by how much money they make, but the types of papers they publish. Their work has been reviewed with a fine-tooth comb by other experts in the field assessing the validity of their statements. Every step of the way in developing their product, Elephas publishes peer-reviewed papers and attends professional conferences to share their results.

🤝 Get involved with Elephas